You may obtain copies of all documents filed with the SEC regarding this transaction, free of charge, at the SEC's website ( http://www.sec.gov ). You may also obtain these documents, free of charge, from ViroPharma's website ( http://www.viropharma.com ) under the tab "Investors" and then under the item "SEC Filings". You may also obtain these documents, free of charge, from Lev's website ( http://www.levpharma.com ) under the tab "Investor Relations" and then under the heading "SEC Filings."
ViroPharma, Lev and their respective directors, executive officers and certain other members of management and employees may be soliciting proxies from Lev stockholders in favor of the merger. Information regarding the persons who may, under the rules of the SEC, be considered participants in the solicitation of the Lev stockholders in connection with the proposed merger will be set forth in the proxy statement/prospectus when it is filed with the SEC. You can find information about ViroPharma's executive officers and directors in its definitive proxy statement filed with the SEC on April 11, 2008. You can find information about Lev's executive officers and directors in definitive proxy statement filed with the SEC on April 16, 2008. You can obtain free copies of these documents from ViroPharma and Lev using the contact information above.
|SOURCE ViroPharma Incorporated|
Copyright©2008 PR Newswire.
All rights reserved